Opioid Use Disorder Clinical Trials in Indianapolis, Indiana

4 studies are recruiting for opioid use disorder in Indianapolis, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

   This study is examining the use of Tezampanel (TZP) for treatment of Opioid Withdrawal Syndrome (OWS) in participants with Opioid Use Disorder (OUD). Participants will receive TZP or placebo (PBO) daily on Days 2 - 7 during a 7-day inpatient stay at the research center to determine safety, pharmaco…

   Stage

   Phase 1

   Ages

   18 to 65

   Site

   Indiana University School of Medicine, Indianapolis, Indiana

   Run by

   Proniras Corporation

   See if you can join NCT06538558 on ClinicalTrials.gov

2. A Study of Brenipatide in Participants With Opioid Use Disorder

   The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when used with buprenorphine with or without naloxone. The maximum potential duration of study participation for a participant in Part A is approximately 14…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Indiana University Health Neuroscience Center, Indianapolis, Indiana

   Locations

   59 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07420283 on ClinicalTrials.gov

3. Cerebral Physiology of NOWS

   This study will use a new device to measure blood flow and oxygen levels in the brains of newborn infants who have had exposure to opioid medications in the womb, compared to newborns who have not had any exposure.

   Stage

   Not phased

   Ages

   Up to 0

   Site

   Indiana University - Riley Hospital for Children, Indianapolis, Indiana

   Run by

   Indiana University

   See if you can join NCT07610746 on ClinicalTrials.gov

4. AvertD Post-Approval Study

   A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population

   Stage

   Not phased

   Ages

   18 and older

   Site

   Concentrics Research, Indianapolis, Indiana

   Run by

   Prescient Medicine Holdings, Inc.

   See if you can join NCT07135323 on ClinicalTrials.gov